Edition:
United States

Profile: Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

324.10INR
26 May 2017
Change (% chg)

Rs-0.45 (-0.14%)
Prev Close
Rs324.55
Open
Rs324.95
Day's High
Rs330.00
Day's Low
Rs323.10
Volume
85,577
Avg. Vol
94,245
52-wk High
Rs430.10
52-wk Low
Rs163.50

Claris Lifesciences Limited is a holding company. The Company is engaged in manufacturing of drugs and pharmaceutical products. The Company's geographical segments are India and Outside India. The Company's subsidiary, Claris Injectables Limited, is engaged in specialty Injectables business. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective's, critical care, and nephrology. The Company, through Claris Otsuka Private Limited, is engaged in infusion products business across therapeutic segments, including infusion therapy, parenteral nutrition and plasma volume expanders. Its products are offered through various delivery systems, such as glass and plastic bottles, ampoules and bags. The Company provides its services to government and semi-government institutions, group corporate hospitals and nursing homes.

Company Address

Claris Lifesciences Ltd

1 Corporate Towers
Nr. Parimal Crossing, Ellisbridg
AHMEDABAD     380006
P: +9179.26563331
F: +9179.26408053

Company Web Links